These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38813007)

  • 1. Tripartite motif protein 6 promotes hepatocellular carcinoma progression via multiple pathways.
    Zhang Y; Yuan L; Cui S; Wu S
    Turk J Med Sci; 2023; 53(5):1032-1044. PubMed ID: 38813007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.
    Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X
    Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1.
    Zheng S; Zhou C; Wang Y; Li H; Sun Y; Shen Z
    J Exp Clin Cancer Res; 2020 Jan; 39(1):23. PubMed ID: 31992359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Tripartite Motif Conaining 55 (TRIM55) Inhibits Migration and Invasion of Hepatocellular Carcinoma (HCC) Cells via Epithelial-Mesenchymal Transition and Matrix Metalloproteinase-2 (MMP2).
    Li X; Huang L; Gao W
    Med Sci Monit; 2019 Jan; 25():771-777. PubMed ID: 30685767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated TRIM11 Exerts its Oncogenic Effects in Hepatocellular Carcinoma Through Inhibition of P53.
    Liu J; Rao J; Lou X; Zhai J; Ni Z; Wang X
    Cell Physiol Biochem; 2017; 44(1):255-266. PubMed ID: 29190611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tripartite motif-containing protein 7 regulates hepatocellular carcinoma cell proliferation via the DUSP6/p38 pathway.
    Hu X; Tang Z; Ma S; Yu Y; Chen X; Zang G
    Biochem Biophys Res Commun; 2019 Apr; 511(4):889-895. PubMed ID: 30850165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA TRIM52-AS1 Sponges miR-514a-5p to Facilitate Hepatocellular Carcinoma Progression Through Increasing MRPS18A.
    Zhou C; Chen Z; Peng C; Chen C; Li H
    Cancer Biother Radiopharm; 2021 Mar; 36(2):211-219. PubMed ID: 32391716
    [No Abstract]   [Full Text] [Related]  

  • 9. TRIM50 suppressed hepatocarcinoma progression through directly targeting SNAIL for ubiquitous degradation.
    Ma X; Ma X; Qiu Y; Zhu L; Lin Y; You Y; Ma D; Qin Z; Sun C; Zhao Y; Sun Y; Han L
    Cell Death Dis; 2018 May; 9(6):608. PubMed ID: 29789583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
    Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L
    Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma.
    Yang YF; Zhang MF; Tian QH; Zhang CZ
    J Cell Sci; 2017 Sep; 130(18):3108-3115. PubMed ID: 28754688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
    Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
    Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
    [No Abstract]   [Full Text] [Related]  

  • 14. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
    Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY
    Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immature colon carcinoma transcript-1 promotes cell growth of hepatocellular carcinoma via facilitating cell cycle progression and apoptosis resistance.
    Chang W; Yu Z; Tian M; Lin X
    Oncol Rep; 2017 Dec; 38(6):3489-3496. PubMed ID: 29130100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA‑29c‑3p acts as a tumor suppressor gene and inhibits tumor progression in hepatocellular carcinoma by targeting TRIM31.
    Lv T; Jiang L; Kong L; Yang J
    Oncol Rep; 2020 Mar; 43(3):953-964. PubMed ID: 32020206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tripartite motif-containing protein 6 facilitates growth and migration of breast cancer through degradation of STUB1.
    Wei C; Wu J; Liu W; Lu J; Li H; Hai B
    Eur J Histochem; 2021 Mar; 65(1):. PubMed ID: 33728863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
    Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
    J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
    Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
    Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis.
    Ma XL; Shen MN; Hu B; Wang BL; Yang WJ; Lv LH; Wang H; Zhou Y; Jin AL; Sun YF; Zhang CY; Qiu SJ; Pan BS; Zhou J; Fan J; Yang XR; Guo W
    J Hematol Oncol; 2019 Apr; 12(1):37. PubMed ID: 30971294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.